Intest Res.  2018 Jan;16(1):126-133. 10.5217/ir.2018.16.1.126.

Three-year colonoscopy surveillance after polypectomy in Korea: a Korean Association for the Study of Intestinal Diseases (KASID) multicenter prospective study

Affiliations
  • 1Department of Internal Medicine, Hanyang University Guri Hospital, Guri, Korea. hands@hanyang.ac.kr
  • 2Department of Internal Medicine, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • 3Department of Internal Medicine, University of Ulsan College of Medicine, Seoul, Korea.
  • 4Department of Internal Medicine, Ewha Womans University School of Medicine, Seoul, Korea.
  • 5Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
  • 6Department of Internal Medicine, Hallym University Medical Center, Anyang, Korea.
  • 7Department of Internal Medicine, Soonchunhyang University College of Medicine, Cheonan, Korea.
  • 8Department of Internal Medicine, The Catholic University of Korea Incheon St. Mary's Hospital, Incheon, Korea.
  • 9Department of Internal Medicine, Ajou University School of Medinie, Suwon, Korea.
  • 10Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.
  • 11Department of Internal Medicine, Yonsei University College of Medicine, Wonju, Korea.
  • 12Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, USA.

Abstract

BACKGROUND/AIMS
Colonoscopic surveillance is currently recommended after polypectomy owing to the risk of newly developed colonic neoplasia. However, few studies have investigated colonoscopy surveillance in Asia. This multicenter and prospective study was undertaken to assess the incidence of advanced adenoma based on baseline adenoma findings at 3 years after colonoscopic polypectomy.
METHODS
A total of 1,323 patients undergoing colonoscopic polypectomy were prospectively assigned to 3-year colonoscopy surveillance at 11 tertiary endoscopic centers. Relative risks for advanced adenoma after 3 years were calculated according to baseline adenoma characteristics.
RESULTS
Among 1,323 patients enrolled, 387 patients (29.3%) were followed up, and the mean follow-up interval was 31.0±9.8 months. The percentage of patients with advanced adenoma on baseline colonoscopy was higher in the surveillance group compared to the non-surveillance group (34.4% vs. 25.7%). Advanced adenoma recurrence was observed in 17 patients (4.4%) at follow-up. The risk of advanced adenoma recurrence was 2 times greater in patients with baseline advanced adenoma than in those with baseline non-advanced adenoma, though the difference was not statistically significant (6.8% [9/133] vs. 3.1% [8/254], P=0.09). Advanced adenoma recurrence was observed only in males and in subjects aged ≥50 years. In contrast, adenoma recurrence was observed in 187 patients (48.3%) at follow-up. Male sex, older age (≥50 years), and multiple adenomas (≥3) at baseline were independent risk factors for adenoma recurrence.
CONCLUSIONS
A colonoscopy surveillance interval of 3 years in patients with baseline advanced adenoma can be considered appropriate.

Keyword

Colonoscopy; Colonic polyps; Surveillance; Recurrence; Adenoma

MeSH Terms

Adenoma
Asia
Colon
Colonic Polyps
Colonoscopy*
Follow-Up Studies
Humans
Incidence
Korea*
Male
Prospective Studies*
Recurrence
Risk Factors

Cited by  2 articles

Appropriate Surveillance Interval after Colonoscopic Polypectomy in Patients Younger than 50 Years
Yoon Suk Jung, Nam Hee Kim, Jung Ho Park, Dong Il Park, Chong Il Sohn
J Korean Med Sci. 2019;34(12):.    doi: 10.3346/jkms.2019.34.e101.

Postgastrectomy gastric cancer patients are at high risk for colorectal neoplasia: a case control study
Tae-Geun Gweon, Kyu-Tae Yoon, Chang Hyun Kim, Jin-Jo Kim
Intest Res. 2021;19(2):239-246.    doi: 10.5217/ir.2020.00009.


Reference

1. Lieberman DA, De Garmo PL, Fleischer DE, Eisen GM, Helfand M. Patterns of endoscopy use in the United States. Gastroenterology. 2000; 118:619–624. PMID: 10702214.
Article
2. Winawer S, Fletcher R, Rex D, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. Gastroenterology. 2003; 124:544–560. PMID: 12557158.
Article
3. Chung SJ, Kim YS, Yang SY, et al. Five-year risk for advanced colorectal neoplasia after initial colonoscopy according to the baseline risk stratification: a prospective study in 2452 asymptomatic Koreans. Gut. 2011; 60:1537–1543. PMID: 21427200.
Article
4. Lieberman DA, Weiss DG, Harford WV, et al. Five-year colon surveillance after screening colonoscopy. Gastroenterology. 2007; 133:1077–1085. PMID: 17698067.
Article
5. Kim TO. Optimal colonoscopy surveillance interval after polypectomy. Clin Endosc. 2016; 49:359–363. PMID: 27484812.
Article
6. Bogie R, Sanduleanu S. Optimizing post-polypectomy surveillance: a practical guide for the endoscopist. Dig Endosc. 2016; 28:348–359. PMID: 26179809.
Article
7. Lieberman DA, Rex DK, Winawer SJ, Giardiello FM, Johnson DA, Levin TR. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2012; 143:844–857. PMID: 22763141.
Article
8. Matsuda T, Chiu HM, Sano Y, Fujii T, Ono A, Saito Y. Surveillance colonoscopy after endoscopic treatment for colorectal neoplasia: From the standpoint of the Asia-Pacific region. Dig Endosc. 2016; 28:342–347. PMID: 26861487.
Article
9. Bosman FT, Carneiro F, Hruban RH, Theise ND. WHO classification of tumours of the digestive system. 4th ed. Lyon: IARC;2010.
10. Kim ER, Kim YH. Clinical application of genetics in management of colorectal cancer. Intest Res. 2014; 12:184–193. PMID: 25349592.
Article
11. Cha JM. Colonoscopy quality is the answer for the emerging issue of interval cancer. Intest Res. 2014; 12:110–116. PMID: 25349577.
Article
12. Jang HW, Park SJ, Hong SP, Cheon JH, Kim WH, Kim TI. Risk factors for recurrent high-risk polyps after the removal of high-risk polyps at initial colonoscopy. Yonsei Med J. 2015; 56:1559–1565. PMID: 26446637.
Article
13. Sung JJ, Ng SC, Chan FK, et al. An updated Asia Pacific consensus recommendations on colorectal cancer screening. Gut. 2015; 64:121–132. PMID: 24647008.
Article
14. Baxter NN, Goldwasser MA, Paszat LF, Saskin R, Urbach DR, Rabeneck L. Association of colonoscopy and death from colorectal cancer. Ann Intern Med. 2009; 150:1–8. PMID: 19075198.
Article
15. Winawer SJ, Zauber AG, O'Brien MJ, et al. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps: the National Polyp Study Workgroup. N Engl J Med. 1993; 328:901–906. PMID: 8446136.
Article
16. Loeve F, van Ballegooijen M, Snel P, Habbema JD. Colorectal cancer risk after colonoscopic polypectomy: a population-based study and literature search. Eur J Cancer. 2005; 41:416–422. PMID: 15691642.
Article
17. Citarda F, Tomaselli G, Capocaccia R, Barcherini S, Crespi M. Italian Multicentre Study Group. Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence. Gut. 2001; 48:812–815. PMID: 11358901.
Article
18. Alberts DS, Martínez ME, Roe DJ, et al. Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas: Phoenix Colon Cancer Prevention Physicians' Network. N Engl J Med. 2000; 342:1156–1162. PMID: 10770980.
Article
19. Baron JA, Cole BF, Sandler RS, et al. A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med. 2003; 348:891–899. PMID: 12621133.
20. Alberts DS, Martínez ME, Hess LM, et al. Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence. J Natl Cancer Inst. 2005; 97:846–853. PMID: 15928305.
Article
21. Martínez ME, Baron JA, Lieberman DA, et al. A pooled analysis of advanced colorectal neoplasia diagnoses after colonoscopic polypectomy. Gastroenterology. 2009; 136:832–841. PMID: 19171141.
Article
22. Martínez ME, Sampliner R, Marshall JR, Bhattacharyya AK, Reid ME, Alberts DS. Adenoma characteristics as risk factors for recurrence of advanced adenomas. Gastroenterology. 2001; 120:1077–1083. PMID: 11266371.
Article
23. Huang Y, Gong W, Su B, et al. Recurrence and surveillance of colorectal adenoma after polypectomy in a southern Chinese population. J Gastroenterol. 2010; 45:838–845. PMID: 20336471.
Article
24. Matsuda T, Fujii T, Sano Y, et al. Five-year incidence of advanced neoplasia after initial colonoscopy in Japan: a multicenter retrospective cohort study. Jpn J Clin Oncol. 2009; 39:435–442. PMID: 19483205.
Article
25. Leung WK, Lau JY, Suen BY, et al. Repeat-screening colonoscopy 5 years after normal baseline-screening colonoscopy in average-risk Chinese: a prospective study. Am J Gastroenterol. 2009; 104:2028–2034. PMID: 19455125.
Article
26. Bertario L, Russo A, Sala P, et al. Predictors of metachronous colorectal neoplasms in sporadic adenoma patients. Int J Cancer. 2003; 105:82–87. PMID: 12672034.
Article
27. Nusko G, Mansmann U, Kirchner T, Hahn EG. Risk related surveillance following colorectal polypectomy. Gut. 2002; 51:424–428. PMID: 12171968.
Article
28. Fossi S, Bazzoli F, Ricciardiello L, et al. Incidence and recurrence rates of colorectal adenomas in first-degree asymptomatic relatives of patients with colon cancer. Am J Gastroenterol. 2001; 96:1601–1604. PMID: 11374706.
Article
29. Sass DA, Schoen RE, Weissfeld JL, et al. Relationship of visceral adipose tissue to recurrence of adenomatous polyps. Am J Gastroenterol. 2004; 99:687–693. PMID: 15089903.
Article
30. Jacobs ET, Ahnen DJ, Ashbeck EL, et al. Association between body mass index and colorectal neoplasia at follow-up colonoscopy: a pooling study. Am J Epidemiol. 2009; 169:657–666. PMID: 19147743.
Article
31. Reid ME, Marshall JR, Roe D, et al. Smoking exposure as a risk factor for prevalent and recurrent colorectal adenomas. Cancer Epidemiol Biomarkers Prev. 2003; 12:1006–1011. PMID: 14578135.
32. Paskett ED, Reeves KW, Pineau B, et al. The association between cigarette smoking and colorectal polyp recurrence (United States). Cancer Causes Control. 2005; 16:1021–1033. PMID: 16184467.
Article
33. Gao F, Liao C, Liu L, Tan A, Cao Y, Mo Z. The effect of aspirin in the recurrence of colorectal adenomas: a meta-analysis of randomized controlled trials. Colorectal Dis. 2009; 11:893–901. PMID: 19055515.
Article
34. Wei JT, Mott LA, Baron JA, Sandler RS. Polyp Prevention Study Group. Reported use of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors was not associated with reduced recurrence of colorectal adenomas. Cancer Epidemiol Biomarkers Prev. 2005; 14:1026–1027. PMID: 15824186.
35. van Heijningen EM, Lansdorp-Vogelaar I, Kuipers EJ, et al. Features of adenoma and colonoscopy associated with recurrent colorectal neoplasia based on a large community-based study. Gastroenterology. 2013; 144:1410–1418. PMID: 23499951.
36. Bonithon-Kopp C, Piard F, Fenger C, et al. Colorectal adenoma characteristics as predictors of recurrence. Dis Colon Rectum. 2004; 47:323–333. PMID: 14991494.
37. Seo JY, Chun J, Lee C, et al. Novel risk stratification for recurrence after endoscopic resection of advanced colorectal adenoma. Gastrointest Endosc. 2015; 81:655–664. PMID: 25500328.
38. Cairns SR, Scholefield JH, Steele RJ, et al. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut. 2010; 59:666–689. PMID: 20427401.
Article
Full Text Links
  • IR
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr